Wikipedia -WSS

Wikipedia

author：Wikipedia 2025-10-06 07:54:58 - browse：642

parts of a dna helix fades while a segment stays solid — Adobe

Flagship Pioneering, the venture capital firm behind Moderna, on Tuesday unveiled a new biotech called Quotient Therapeutics that will have offices in Massachusetts and the United Kingdom.

Quotient, which was founded last year and had operated in stealth mode, wants to develop drugs that target illnesses caused by genetic changes that occur as people age. Those conditions include immune diseases, cancers, neurodegenerative illnesses, and cardiometabolic disorders, such as heart attacks, strokes and diabetes.

With an initial of $50 million from the venture firm Flagship Pioneering, Quotient will be located in Cambridge, Mass., and Cambridge, England. Most of the academic co-founders work in the UK city. Quotient is the first Flagship-backed biotech that will be based in both countries.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Health insurers' Q3 question: how much care are people getting?

WSS

With Roe v Wade overturned, abortion providers work to adapt

Flu, Covid vaccination rates decline, new survey data show

What drug price negotiations mean for Medicare Part D

Weighted lottery helped low

Medicare innovation center doesn’t save money, experts say

Stop Congress from blocking public access to science

hotspot

Wikipedia

hotspot

United colonoscopy coverage change 'may cost lives,' doctors say

European officials brace for rough respiratory virus season

Dobbs anniversary: the lost opportunity of abortion as health care

Nobel honors Karikó and Weissman's enduring partnership

Tori Bowie and the unacceptable rates of Black maternal death

A rare thyroid diagnosis led to unexpected, all

Moonlake's readout produced a cash windfall. Risks remain

2023 Nobel Prize in Medicine goes to Karikó and Weissman

DIEP, the 'gold standard' of breast reconstruction, is under threat

Study points to new risk in gene therapy death of Terry Horgan

focus

European officials brace for rough respiratory virus season

A rare thyroid diagnosis led to unexpected, all

Listen: Biogen's potential pivot, & Illumina's next chapter

Ethical issues complicate the benefits of medical crowdfunding

What will Novo Nordisk's VC do with its influx of cash?

6 solutions to address cancer drug shortages and others

explore

explore

Wikipedia

knowledge